We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M Turnover 30.23%
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-6.55%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$4.6B
AUM Growth
-$358M
Cap. Flow
+$124M
Cap. Flow %
2.69%
Top 10 Hldgs %
84.57%
Holding
69
New
20
Increased
2
Reduced
18
Closed
6
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.6 years

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$82.3M
2
BABA icon
Alibaba
BABA
+$78.9M
3
RYZB icon
RayzeBio, Inc. Common Stock
RYZB
+$66M
4
DASH icon
DoorDash
DASH
+$52.9M
5
BIDU icon
Baidu
BIDU
+$41M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Healthcare 33.02%
3 Technology 15.02%
4 Real Estate 8.7%
5 Communication Services 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALGS icon
51
Aligos Therapeutics
ALGS
$30.3M
$1.87M 0.04%
76,248
– –
2020 Q4
13 quarters
JD icon
52
JD.com
JD
$36.5B
$1.68M 0.04%
61,250
-1,389,900
-96% -$34M
2018 Q4
21 quarters
PYXS icon
53
Pyxis Oncology
PYXS
$140M
$1.63M 0.04%
382,606
– –
2021 Q4
9 quarters
MOGU icon
54
MOGU Inc
MOGU
$15.5M
$1.6M 0.03%
847,510
– –
2019 Q2
19 quarters
BZ icon
55
Kanzhun
BZ
$7.33B
$1.56M 0.03%
89,100
-34,600
-28% -$546K
2022 Q2
7 quarters
ANET icon
56
Arista Networks
ANET
$223B
$1.04M 0.02%
+14,400
New +$971K
2024 Q1
0 quarters
ATAT icon
57
Atour Lifestyle Holdings
ATAT
$4.55B
$897K 0.02%
50,000
-150,000
-75% -$2.75M
2022 Q4
5 quarters
LSB
58
DELISTED
LakeShore Biopharma
LSB
$526K 0.01%
75,179
– –
2023 Q1
4 quarters
QCOM icon
59
Qualcomm
QCOM
$184B
$508K 0.01%
+3,000
New +$464K
2024 Q1
0 quarters
YMM icon
60
Full Truck Alliance
YMM
$9.08B
$98.3K ﹤0.01%
13,519
-2,239,023
-99% -$14.9M
2022 Q1
8 quarters
RDGT icon
61
Ridgetech Inc
RDGT
$3.04M
$62.9K ﹤0.01%
134
– –
2019 Q3
18 quarters
CEG icon
62
Constellation Energy
CEG
$96.1B
$55.5K ﹤0.01%
+300
New +$42.6K
2024 Q1
0 quarters
UXIN icon
63
Uxin Ltd
UXIN
$222M
$40.6K ﹤0.01%
19,156
– –
2019 Q3
18 quarters
DDOG icon
64
Datadog
DDOG
$88.7B
– –
-85,100
Closed -$10.3M –
FUTU icon
65
Futu Holdings
FUTU
$14.8B
– –
-80,000
Closed -$4.37M –
IQ icon
66
iQIYI
IQ
$918M
– –
-142,500
Closed -$695K –
NMRA icon
67
Neumora Therapeutics
NMRA
$89M
– –
-1,699,313
Closed -$29M –
PLTK icon
68
Playtika
PLTK
$805M
– –
-72,800
Closed -$635K –
RYZB icon
69
DELISTED
RayzeBio, Inc. Common Stock
RYZB
– –
-1,062,383
Closed -$66M –

Similar funds

HHLR Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, HHLR Advisors held 69 positions worth $4.6B, down 7.2% from $4.96B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

HHLR Advisors's Q1 2024 filing shows 20 new, 2 increased, 18 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 912,400 shares worth $165M. The largest sale was Salesforce, an estimated $82.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.

  • HHLR Advisors's largest Q1 2024 buy was Advanced Micro Devices: 912,400 shares worth $165M.
  • HHLR Advisors added most to Pinduoduo in Q1 2024, an estimated $220M increase.
  • HHLR Advisors's biggest Q1 2024 reduction was Salesforce, cutting an estimated $82.3M.
  • HHLR Advisors fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $66M.
  • HHLR Advisors's ten largest holdings make up 85% of its $4.6B portfolio in Q1 2024.
  • HHLR Advisors opened 20 new positions and closed 6 in Q1 2024.
  • HHLR Advisors's portfolio value fell 7.2% quarter-over-quarter to $4.6B.

Based on HHLR Advisors's 13F filing for Q1 2024, filed 14 May 2024.